Robert B. Gerbing

17.8k citations
239 papers · 11.2k · 4 hit papers · h-index 51

Impact in

  • Neurology top 0.05%
    • Neuroblastoma Research and Treatments
  • Hematology top 0.1%
    • Acute Myeloid Leukemia Research
    • Hematopoietic Stem Cell Transplantation

Papers in

    • Acute Myeloid Leukemia Research 159
    • Multiple Myeloma Research and Treatments 22
    • Hematopoietic Stem Cell Transplantation 19
    • Protein Degradation and Inhibitors 20

Robert B. Gerbing

234 papers receiving 11.0k citations

Robert B. Gerbing's Hit Papers

Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Event-Free Survival by Reducing Relapse Risk: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531 2014 · 320 citations
3200+9+18Years since publication4008001.2k

Peers

Robert B. Gerbing
Comparison fields: 5 of 118
  • Neurology 4.9k
  • Hematology 3.6k
  • Cancer Research 1.5k
  • Genetics 921
  • Oncology 1.6k
Replace Joachim Yahalom with:
Joachim Yahalom United States
Anton Hagenbeek Netherlands
Sherrie L. Perkins United States
Alberto S. Pappo United States
Michael Crump Canada
Jonathan W. Friedberg United States
Steven G. DuBois United States
Catherine Thiéblemont France
Sherry Pierce United States
D Maraninchi France
Robert B. Gerbing relative to Joachim Yahalom United States Joachim Yahalom's profile →
Citations per field
00.5×3.4×
Joachim Yahalom · 1×
Citations per year

Countries citing papers authored by Robert B. Gerbing

Since Specialization
Citations

This map shows the geographic impact of Robert B. Gerbing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert B. Gerbing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert B. Gerbing more than expected).

Fields of papers citing papers by Robert B. Gerbing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert B. Gerbing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert B. Gerbing. The network helps show where Robert B. Gerbing may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert B. Gerbing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert B. Gerbing Line = papers co-authored together Robert B. Gerbing links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 239 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid
Hit paper breakdown →
19991437
2
The International Neuroblastoma Pathology Classification (the Shimada system)
Hit paper breakdown →
1999742
3
Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study
Hit paper breakdown →
2009630
4
Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Event-Free Survival by Reducing Relapse Risk: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531
Hit paper breakdown →
2014320
5 1999316
6 2006271
7 2011210
8 2001204
9 2007199
10 2012186
11 1999182
12 2007179
13 2003173
14 2001161
15 2000160
16 1998157
17 2000156
18 2000150
19 2001140
20 2011139

About Robert B. Gerbing

Robert B. Gerbing is a scholar working on Hematology, Molecular Biology, Public Health, Environmental and Occupational Health, Neurology and Oncology, having authored 239 papers that have together received 11.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (159 papers), Acute Lymphoblastic Leukemia research (57 papers), Neuroblastoma Research and Treatments (35 papers), Multiple Myeloma Research and Treatments (22 papers), Protein Degradation and Inhibitors (20 papers), Hematopoietic Stem Cell Transplantation (19 papers), Neutropenia and Cancer Infections (17 papers) and Cancer Genomics and Diagnostics (14 papers). The work is most often cited by research in Neurology (4.9k citations), Hematology (3.6k citations), Cancer Research (1.5k citations), Genetics (921 citations) and Oncology (1.6k citations). Robert B. Gerbing has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Todd A. Alonzo, Katherine K. Matthay, Hiroyuki Shimada, Daniel O. Stram, Robert C. Seeger, Soheil Meshinchi, Alan S. Gamis, Beverly J. Lange, Garrett M. Brodeur and John N. Lukens. Their work appears in journals such as Blood, Journal of Clinical Oncology, Pediatric Blood & Cancer, Cancer and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact